Acceleron Pharma Inc.
Records under this name other than the patents Acceleron Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 135 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,059,756 | Compositions Comprising ALK1-ECD Protein Formerly held In force · Low confidence | In force | Low confidence | |
| US 8,158,584 | Pharmaceutical Preparations Comprising an ALK1-FC Fusion Protein Formerly held In force · High confidence | In force | High confidence | |
| US 8,703,927 | Isolated nucleotide sequences encoding GDF traps Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,809,636 | Methods for increasing red blood cell levels comprising administering BMP9 Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,344,066 | Methods and compositions for increasing red blood cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,829,534 | Methods and compositions for increasing red blood cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,682,392 | Methods for Treating Pulmonary Hypertension with a Tgf-Beta Type II Receptor-Fc Fusion Protein Formerly held In force · High confidence | In force | High confidence | |
| US 11,951,156 | Methods for Treating Pulmonary Hypertension with a Ligand Binding Domain of a Tgf-Beta Type II Receptor Formerly held In force · High confidence | In force | High confidence | |
| US 10,603,359 | Methods and compositions using GDF15 polypeptides for increasing red blood cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,642,394 | Methods and Compositions Using GDF15 Polypeptides for Increasing Red Blood Cells Formerly held In force · Low confidence | In force | Low confidence |